ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

304
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
26 Dec 2018 07:42

Korean Stock Market Sectors 2018 Review & 2019 Outlook

In this report, we review the major sectors' performance in the Korean stock market in 2018 and also provide our outlook for them in 2019. We...

Logo
951 Views
Share
bearishCelltrion Inc
13 Dec 2018 10:06

Celltrion / Celltrion Healthcare Pair Trade: Ratio Should Move in Favor of Healthcare

I initiated a pair trade (short Celltrion / long Healthcare) on Oct 22. Yield peaked at 16.66% on Nov 22. It now stays at 8.75%. The ongoing FSS...

Logo
548 Views
Share
02 Dec 2018 21:29

The Smartkarma Week That Was in JP/KR: Nissan, J-Retail, Tesla/Panny, SK Rights, Biosimilars, Trade

This past week featured ~160 insights across the Smartkarma platform, with 35+ of them dealing with Japan, South Korea, and semiconductors/memory...

Logo
899 Views
Share
bearishCelltrion Inc
28 Nov 2018 00:29

Biosimilar Battlefield Update: It's Getting Uglier

A confluence of negative news is causing sharp declines (or trading suspensions) in the share prices of Samsung Biologics Co., (207940...

Share
27 Nov 2018 05:23

EM Health Care:  Late Cycle Rotation

Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...

Logo
339 Views
Share
x